Relation Between Bone Mineral Density, Gross Motor Function and Quality of Life In Children With Cerebral Palsy
NCT ID: NCT06180395
Last Updated: 2024-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
75 participants
OBSERVATIONAL
2024-01-10
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Statement of the problem Is there a relation between Bone Mineral Density, Gross Motor Function and Quality of Life in children with CP ? Purpose of the study
To study the relationship between:
1. Bone Mineral Density and Gross Motor Function in ambulant and non-ambulant CP children.
2. Bone Mineral Density and Quality of Life in ambulant and non-ambulant CP children.
3. Gross Motor Function and Quality of Life in ambulant and non-ambulant CP children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between Body Mass Index, Selective Motor Control and Functional Ability in Children With CP
NCT05428865
Predictors of Range of Motion and Balance Abnormalities in Children Diagnosed with Cerebral Palsy
NCT06601569
Correlation Between Clinical Measurement Scales for Gross Motor Function
NCT06124352
Pulmonary Functions in Relation to Gross Motor Function Level
NCT05271123
Selective Motor Control and Upper Extremity Functions in Children With Hemiparetic Cerebral Palsy
NCT04695639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Children with CP often experience motor impairments that affect their gross motor function, leading to limitations in activities and participation. These motor impairments can also have a negative impact on bone health, resulting in reduced bone mineral density (BMD) and increased risk of skeletal complications.
Gross motor function (GMF) refers to the ability to perform coordinated movements using large muscle groups, such as walking, running, and jumping. It is a key aspect of physical ability and independence in daily activities for children with CP. Previous research has shown that gross motor function is closely associated with bone health in this population. However, further investigation is needed to explore the specific nature of this correlation and its implications for intervention strategies.
Gross motor function is commonly assessed using standardized tools such as the Gross Motor Function Classification System (GMFCS) or the Gross Motor Function Measure (GMFM). Quality of life is a multidimensional construct that encompasses physical, psychological, and social well-being. In the context of cerebral palsy, understanding the impact of gross motor function on quality of life is crucial for comprehensive care and intervention planning. Children with CP may face limitations in mobility, participation in activities, and social interactions, which can significantly affect their overall quality of life. Exploring the relationship between gross motor function and quality of life can provide valuable insights into the factors influencing the holistic well-being of children with CP.
The quality of life in children with CP is not only influenced by their motor function but also by their overall health and well-being. Bone health plays a crucial role in maintaining the physical abilities and independence of individuals, as well as their overall quality of life. Impaired bone health in children with CP can lead to limitations in mobility, increased pain, and reduced participation in activities, which can have a significant impact on their overall well-being.
Bone mineral density, on the other hand, is an important measure of bone strength and overall skeletal health. Children with CP often exhibit lower BMD compared to typically developing peers due to factors such as reduced weight-bearing activities, muscle weakness, altered biomechanics, limited mobility, and hormonal imbalances. This reduced BMD increases their susceptibility to fractures and skeletal deformities, further impacting their functional abilities and quality of life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (Ambulant )
consisted of 37 children with CP classified to level I, II and III according to GMFCS., then:
1. Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD).
2. Gross motor function measurement scale (GMFM) will be used to assess gross motor function.
3. Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).
Group 1
consisted of 37 children with CP classified to level I, II and III according to GMFCS., then:
Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD).
Gross motor function measurement scale (GMFM) will be used to assess gross motor function.
Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).
Group 2 (Non-Ambulant )
consisted of 38 children with CP classified to level IV and V according to GMFCS.then:
1. Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD).
2. Gross motor function measurement scale (GMFM) will be used to assess gross motor function.
3. Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).
Group 2
consisted of 38 children with CP classified to level IV and V according to GMFCS. then:
Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD).
Gross motor function measurement scale (GMFM) will be used to assess gross motor function.
Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 1
consisted of 37 children with CP classified to level I, II and III according to GMFCS., then:
Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD).
Gross motor function measurement scale (GMFM) will be used to assess gross motor function.
Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).
Group 2
consisted of 38 children with CP classified to level IV and V according to GMFCS. then:
Dual-energy X-ray absorptiometry (DXA) scans will be used to assess bone mineral density (BMD).
Gross motor function measurement scale (GMFM) will be used to assess gross motor function.
Quality of Life Questionnaire for Children (CP QOL-Child) will be used to assess quality of life (QOL).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Their chronological ages will be ranged from 7 to 10 years.
3. They will be selected from both genders.
4. Their motor function will be at any Level according to GMFCS.
5. Their body mass index (BMI ) will be normal.
Exclusion Criteria
1. Underweight, Overweight or Obese.
2. Epilepsy , kidney problems that make them taking hormonal treatments or drugs affect bone density or taking calcium, vitamin D, steroids during 6 months prior to the study.
3. Fracture in the measurement areas.
4. Hip Flexion deformity more than 30° when posed to measure.
5. Internal metallic fixations in the measurement areas (neck of femur and lumber vertebra from L1-L4).
6. Hyperthyroidism or Hypothyroidism.
7. Hypotonia.
7 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shimaa Talaat Elsayed Emara
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elham Elsayed Salem, professor
Role: STUDY_CHAIR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
faculty of medicine , Cairo University
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
shimaa Emara, M.Sc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CairoU_STE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.